GSK Cuts Unspecified Number of R&D Staffers

GSK has made cuts to an unspecified number of staff in its Research & Development (R&D) division as part of workforce reductions in 202513.

The exact number of affected employees has not been disclosed publicly as of July 17, 202513.

The layoffs come amid a broader trend of job cuts in the biopharma sector in 2025, but no further details regarding departments or specific projects have been reported3.

Sources:

1. https://www.biospace.com/biospace-layoff-tracker

3. https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025